1-TDC 120 Soft Gels count

1-TDC means, 1-TetraDecanol Complex, which is the molecular name. 1TDC™ is a patented blend of fatty acid oils. 1-TDC is a proprietary blend of fatty acid oils from beef tallow derived from grass-fed animals.

 Extremely palatable, since it is derived from beef tallow. Pets see it as a treat...even cats

1TDC™ has an affinity for white blood cells, which makes it a more targeted and effective solution. Additionally, 1TDC™ is transdermal, which gives it the ability to effectively be absorbed and work locally.

Even allergic patient to beef can use 1-TDC,  allergies come from protein and 1TDC™ is a fatty acid. So, your pet should be safe.

It provides support to the Hips & Joints, as well as all muscles, tendons, and ligaments.

Joint health improvements are typically noticeable in one week for small dogs and cats; two weeks for medium size dogs; and three weeks for large dogs. Periodontal improvements can be seen as early as one week and steady improvement will continue over the next two months. Again, steady improvement can be expected over the following two months.

- J. Feline Medicine and Surgery 2019 Topical oral 1-TetraDecanol Complex in the treatment of periodontal disease in cats.

Abstract Objective: The aim of this study was to evaluate the outcomes of the treatment of chronic periodontal disease with an oral application of tetradecanol complex (1-TDC) in cats. ResultsOral treatment with 1-TDC resulted in significant reductions in all parameters of clinical periodontal disease except took mobility at 6 weeks. The 1-TDC group exhibited a statistically significant reduction in pocket depth, clinical attachment loss, gingival index and bleeding on probing after treatment at 6 weeks, whereas the placebo group did not show any significant change. Conclusions and RelevanceChronic inflammation associated with periodontal diseases leads to periodontal tissue destruction. As a result, modulation of the host response has been included in the treatment protocol for periodontal diseases. Fatty acids present anti-inflammatory properties and are being investigated for use in the treatment and prevention of progressive periodontal diseases. 

- Field Study – Penasquitos Pet Clinic, San Diego, CAThe Effect of 1-TetraDecanol Complex (1- TDC) For Improving Quality of Life in Canines.

Abstract: This study investigated whether 1-TetraDecanol Complex (1-TDC) could improve the quality of life (QOL) in arthritic canines. Small and large breed dogs were enlisted in the study regardless of current arthritic medication. The owner completed a questionnaire to identify QOL characteristics. The veterinarian performed physical assessment on major joint structures. Serum and urine were collected using standard veterinarian practices. Animals were assessed prior to and 30 days after supplementation. Dogs consumed dog chews containing a mixture of 1-TDC, dextrates, desiccated liver and hickory flavor. A standard dose of two chews per 20 pounds per day was established. A total of twenty-seven animals were enrolled with three dropping out (age: 10.52.0 yr.; male: 13 male; female: 11). The veterinarian noted that animals with mild to moderate symptoms seemed to respond more favorably than advanced cases. Subjective comments revealed that 75% of owners noted improvement in their pet’s daily QOL. Common observations were that the animals seemed “happier,” “more energetic” and “to have better temperament.” Information obtained from questionnaires indicated that animals exhibited improved gait, stair climbing and affect. There were no changes in serum or urine markers. In summary, the data presented suggests that 1-TDC mixture can be used to assist canines with joint health challenges. However, more research is warranted for elucidating the mechanism of action. In summary: 1-TetraDecanol Complex improved the general disposition and functional ability in dogs suffering from arthritis. These fatty acids offer an alternative to more traditional therapies for treating arthritis in canines.

- J. Feline Medicine and Surgery 2019 Topical oral 1-TetraDecanol Complex in the treatment of periodontal disease in cats.Abstract Objective: The aim of this study was to evaluate the outcomes of the treatment of chronic periodontal disease with an oral application of tetradecanol complex (1-TDC) in cats. ResultsOral treatment with 1-TDC resulted in significant reductions in all parameters of clinical periodontal disease except took mobility at 6 weeks. The 1-TDC group exhibited a statistically significant reduction in pocket depth, clinical attachment loss, gingival index and bleeding on probing after treatment at 6 weeks, whereas the placebo group did not show any significant change. Conclusions and RelevanceChronic inflammation associated with periodontal diseases leads to periodontal tissue destruction. As a result, modulation of the host response has been included in the treatment protocol for periodontal diseases. Fatty acids present anti-inflammatory properties and are being investigated for use in the treatment and prevention of progressive periodontal diseases. 

- Field Study – Penasquitos Pet Clinic, San Diego, CAThe Effect of 1-TetraDecanol Complex (1- TDC) For Improving Quality of Life in Canines.

- J Periodontol 2009; 80:1103-11131-Tetradecanol Complex: Therapeutic Actions in Experimental Periodontitis. Conclusion: The findings suggest that topical application of cetylated monounsaturated fatty acid complex (1-TDC) is a potential therapeutic approach in controlling the progression of chronic periodontal disease.

- J Periodontol 2007; 78:924-9321‐Tetradecanol Complex Reduces Progression of Porphyromonas gingivalis–Induced Experimental Periodontitis in Rabbits. 

Conclusion: Topical application of an esterified monounsaturated fatty acid complex (1‐TDC) was found promising in preventing bone loss, inflammatory cell infiltration, and connective tissue destruction in the rabbit periodontitis model.

 - A Cetylated Fatty Acid Topical Cream with Menthol Reduces Pain and Improves Functional Performance in Individuals with Arthritis. 

Practical Applications – Our data provide further support for the use of a topical cream consisting of a blend of cetylated fatty acids and menthol in the treatment of individuals with arthritis of the knee, elbow, and wrist. In the present investigation, we reported significant improvements in stair-climbing ability, ‘‘up-and-go’’ performance, balance, and range of motion; reductions in pain in individuals with knee OA; significant improvements in dynamic and isometric local muscular endurance; and a reduction in pain in individuals with severe pain in the elbow and wrist. The changes were similar to what we had previously noted. In addition, the use of such topical treatments may allow individuals to better exercise, thereby helping them improve their health and fitness. Strength and conditioning professionals who work with such populations may find that it enhances workout capabilities.

 - J Rheumatol 2002; 29:1708-12Cetylated Fatty Acids Improve Knee Function in Patients with Osteoarthritis.

Conclusion: Compared to placebo, CFA provides an improvement in knee range of motion and overall function in patients with OA of the knee. CFA may be an alternative to the use of nonsteroidal anti-inflammatory drugs for the treatment of OA.